Botanix Pharmaceuticals Ltd. recently announced that three scientific posters related to Sofdra were accepted and exhibited at major dermatology continuing medical education $(CME)$ conferences in October and early November 2025. The posters presented scientific findings to dermatology professionals at these events.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Botanix Pharmaceuticals Ltd. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.